Weijia Fang, Md

This is a very early study to first check if a new cell therapy called KT032 is safe and tolerable for people with advanced cancers like ovarian, mesothelioma, or colon cancer. It will involve about 24 adults whose cancer has progressed despite standard treatments. The main goal …